» Articles » PMID: 34882586

Arthroscopic Versus Open Management of Diffuse-Type Tenosynovial Giant Cell Tumor of the Knee: A Meta-analysis of Retrospective Cohort Studies

Overview
Specialty Orthopedics
Date 2021 Dec 9
PMID 34882586
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Whether arthroscopic or open surgical management for diffuse-type tenosynovial giant cell tumor (D-TGCT) of the knee is associated with a lower rate of recurrence is unknown.

Methods: PubMed, Scopus, Web of Science, Cochrane, and EMBASE were searched on December 3, 2020. Retrospective studies that reported on recurrence rates for arthroscopic versus open management of D-TGCT were included. A total of 16 studies evaluating 1143 patients with D-TGCT of the knee were included (nopen = 551, narthroscopic = 350 patients, and narthroscopic/open = 23 patients). Random-effects meta-analyses were used to summarize and compare the reported recurrence rates, stratified by approach and overall recurrence. The meta-analysis was registered with PROSPERO.

Results: The recurrence rate per year (incidence) for arthroscopic procedures was 0.11 (95% CI 0.08 to 0.16, P < 0.0001) and for open procedures was 0.07 (95% CI 0.04 to 0.13, P < 0.0001). There was a 1.56 times (95% CI 1.04 to 2.34, P = 0.0332) increased risk of recurrence when treating D-TGCT of the knee with an arthroscopic approach. When evaluating only the subset of studies that had data for both arthroscopic and open approaches, the incidence rate per year for arthroscopic procedures was 0.17 (95% CI 0.11 to 0.27, P < 0.0001) and for open procedures was 0.11 (95% CI 0.06 to 0.19, P < 0.0001). The rate of overall complications was 0.04 (95% CI 0.01 to 0.08, P < 0.0001).

Conclusion: Arthroscopic surgical management of D-TGCT of the knee in our study resulted in a 1.56 times risk of recurrence as compared with the open approach. The percent of overall complications was minimal.

Citing Articles

Recurrence of arthroscopic treatment of pigmented villonodular synovitis of the knee: A systematic review and meta-analysis.

Keyhani S, Soleymanha M, Vosoughi F, Nikibakhsh A, Zadgari E, Mousavi M J Exp Orthop. 2025; 12(1):e70169.

PMID: 39931151 PMC: 11808254. DOI: 10.1002/jeo2.70169.


Pigmented Villonodular Synovitis: A Critical Review.

Bernard C, Rooker J, Morey T, Long R, Sweeney K, Powers B Kans J Med. 2025; 17(5):113-118.

PMID: 39758547 PMC: 11698232. DOI: 10.17161/kjm.vol17.21831.


Tenosynovial giant cell tumours: experience at an Australian tertiary referral centre for musculoskeletal tumours with minimum two-year follow-up.

Kim R, Maher A, Karunaratne S, Stalley P, Boyle R Bone Jt Open. 2023; 4(11):846-852.

PMID: 37935246 PMC: 10629998. DOI: 10.1302/2633-1462.411.BJO-2023-0116.R1.


Understanding the Effect of Osteoarthritis on Surgical Treatment Patterns, Healthcare Resource Utilization, and Costs Among Patients With Tenosynovial Giant Cell Tumors.

Lin F, Wilson K, Kwong W, Abraham J J Am Acad Orthop Surg Glob Res Rev. 2023; 7(5).

PMID: 37216288 PMC: 10205369. DOI: 10.5435/JAAOSGlobal-D-23-00047.


One-Stage Synovectomies Result in Improved Short-Term Outcomes Compared to Two-Stage Synovectomies of Diffuse-Type Tenosynovial Giant Cell Tumor (D-TGCT) of the Knee: A Multicenter, Retrospective, Cohort Study.

Spierenburg G, Verspoor F, Wunder J, Griffin A, Ferguson P, Houdek M Cancers (Basel). 2023; 15(3).

PMID: 36765897 PMC: 9913566. DOI: 10.3390/cancers15030941.


References
1.
Colman M, Ye J, Weiss K, Goodman M, McGough 3rd R . Does combined open and arthroscopic synovectomy for diffuse PVNS of the knee improve recurrence rates?. Clin Orthop Relat Res. 2012; 471(3):883-90. PMC: 3563816. DOI: 10.1007/s11999-012-2589-8. View

2.
Schwartz H, Unni K, Pritchard D . Pigmented villonodular synovitis. A retrospective review of affected large joints. Clin Orthop Relat Res. 1989; (247):243-55. View

3.
Shekhar A, Patil S, Dixit C, Tapasvi S . Localized pigmented villonodular synovitis of posterior compartment of the knee. J Orthop Surg (Hong Kong). 2017; 25(3):2309499017727923. DOI: 10.1177/2309499017727923. View

4.
Bernthal N, Ishmael C, Burke Z . Management of Pigmented Villonodular Synovitis (PVNS): an Orthopedic Surgeon's Perspective. Curr Oncol Rep. 2020; 22(6):63. DOI: 10.1007/s11912-020-00926-7. View

5.
Verspoor F, Zee A, Hannink G, van der Geest I, Veth R, Schreuder H . Long-term follow-up results of primary and recurrent pigmented villonodular synovitis. Rheumatology (Oxford). 2014; 53(11):2063-70. DOI: 10.1093/rheumatology/keu230. View